Stryker Tops 2024 Global Orthopedic Revenue Rankings; MicroPort Sole Chinese Firm on List

The global orthopedic market size has expanded to USD 61.9 billion in 2024. According to statistics, eight companies with revenue exceeding USD 1 billion in 2024 account for more than two-thirds of the market share, nine companies with revenue between USD 400 million and USD 900 million account for 8%, and ten companies with revenue between USD 200 million and USD 399 million account for slightly over 4%.

For orthopedic giants, joint replacement is a highly profitable business segment, with new technologies continuously driving growth in this field. Enabling technologies are key to success in the spinal sector, while joint preservation is propelling advancements in sports medicine.

M&A integration in the foot and ankle segment has impacted the trauma market, while bone biologics continue to maintain steady growth driven by the development of therapies for osteoarthritis.

Stryker, Johnson & Johnson,Zimmer Biomet remains the largest orthopedic company globally, with the combined sales of the three companies accounting for nearly half (approximately 44.8%) of the global orthopedic market. The primary source of revenue for these three companies is joint replacement, among which...Zimmer Biomet's joint replacement accounts for up to 73%.

Among the listed companies, MicroPort is the only orthopedic company in China, with a revenue of $2.56 billion. Joint replacement accounts for approximately 97% of its income.